Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Alireza Nami MD
EIR
•Alireza Nami MD•September 18, 2020

Alireza Nami MD – FDA EIR, Sep 18, 2020

Record Details

An FDA inspection was conducted at Alireza Nami MD in Charlotte, NC, from September 14 to September 18, 2020. This "for-cause" inspection, prompted by a report of serious noncompliance, focused on the authority, administration, and conduct of clinical investigations, particularly Protocol ID-(b)(4), under Compliance Program 7348.811, which governs clinical investigators. Numerous significant violations were identified, including the failure to perform essential protocol-required procedures and assessments before administering investigational product, such as missing principal investigator assessments, subject questionnaires, and pharmacokinetic samples. There was insufficient or missing source documentation to verify subject eligibility, and required safety monitoring, like electrocardiograms and cardiac monitor data transmission, was not completed. Furthermore, an untrained study coordinator conducted study visits, and a subject was enrolled despite screening results falling below exclusion criteria. These findings were serious, especially considering a previous 2014 inspection also revealed deviations concerning drug disposition, informed consent, and source documentation. Although no FDA Form 483 (Inspectional Observations) was issued, the deficiencies, already addressed by the site's Corrective and Preventive Action (CAPA) plan, were extensively discussed. The FDA reminded Dr. Nami of the seriousness of the findings and advised continued process improvements to ensure compliance with regulations governing clinical trials under "505 of the Federal Food, Drug, and Cosmetic Act.

Company
Alireza Nami MD
Inspection date
September 18, 2020
Product type
drugs
Office
Atlanta District Office
Person
  • Brandy D. Brown
View Company Profile

ID · e10594a8-ee14-4fbc-a4e1-4cc56891d858

Violation Codes2
FD&C Act 50521 CFR 312

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Alireza Nami MD
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.